Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation. 

GROWTH IS THE KEY

Metropolis Healthcare Ltd

BSE Code: 542650
CMP: ₹1,764.95

Metropolis delivers diagnostic solutions in areas of expertise like Oncology, Neurology, Gynaecology, and many more. It offers a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The diagnostics sector is in a development phase in India, with many players witnessing strong demand from urban and rural India. One of the prominent companies, Metropolis aims to nurture and expand its healthcare solutions by adapting to next-generation sequencing and AI. Post its recent slump, the stock presents itself at an attractive valuation. The growth phase is likely to continue, and long-term investors have a gem to grab in their portfolio!

EXPANSION, PROFITABILITY AND WHATNOT!

JSW Energy Ltd

BSE Code: 533148
CMP: ₹347.80

JSW Energy Limited is an integrated power company primarily engaged in the generation and sale of power. In its recent Q2FY23 result, the company posted a jump of 37 per cent YoY jump in net profit while its revenue rose nearly 15 per cent YoY to Rs 2,387 crore, The company holds plans for expansion and focus on clean energy amidst robust demand. The market has taken the results positively as the stock has surged nearly 10 per cent this week. The stock has registered a triangle pattern breakout which is considered bullish for the medium term. Momentum is the key here, and you mustn’t miss out on this attractive stock!

FAVOURABLE TIMES AHEAD

TORRENT PHARMACEUTICALS LTD

BSE Code: 500420
CMP: ₹1,687.05

Torrent Pharmaceuticals is a pioneer in initiating the concept of niche marketing in India and today is ranked amongst the leaders in the therapeutic segment of cardiovascular, central nervous system, and women's healthcare (WHC). It also has a significant presence in diabetology, pain management, gynaecology, oncology, and antiinfective segments. The stock has attracted significant buying interest from institutions amid the positive outlook of the company. Many brokerage houses and credit agencies have upgraded their target for this stock. With the stock trading at its 52-week high level, one can surely ride out its momentum! 
 

EXPANSION PUSH

J.K.CEMENT LTD

BSE Code: 532644
CMP: ₹2,799.95

JK Cement Ltd is one of India’s leading manufacturers of Grey Cement and White Cement. It has partnered with India's multi-sectoral infrastructure needs on the strength of its product excellence, customer orientation and technology leadership. Recently, it has inaugurated a grey cement grinding unit in Kanpur which has a total production capacity of 2 million tons per annum. It is expected to act as a 'new growth engine' for its grey cement business. Analysts expect such growth plans and the company’s cost-saving measures to drive earnings spontaneously. Meanwhile, this positivity is being reflected in the stock price, as strong institutional buying is prevalent from the recent volumes. Known as the best among its peers, what holds you back from not adding it to your portfolio kitty?